Production (Stage)
Moleculin Biotech, Inc.
MBRX
$0.67
-$0.0201-2.91%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -241.98% | 82.23% | -145.24% | 13.10% | 51.60% |
| Total Depreciation and Amortization | 0.00% | -3.13% | 3.23% | -3.13% | -8.57% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 126.53% | -209.16% | 415.29% | -45.55% | -140.23% |
| Change in Net Operating Assets | -32.50% | 98.11% | 226.32% | 54.81% | -128.78% |
| Cash from Operations | 10.21% | 16.85% | -2.76% | 11.43% | -37.17% |
| Capital Expenditure | -- | -- | 100.00% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 100.00% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 799,800.00% | -99.98% | -- | -- | -- |
| Repurchase of Common Stock | -- | 100.00% | 96.00% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 799,800.00% | -99.98% | 18,736.00% | -- | -- |
| Foreign Exchange rate Adjustments | 106.67% | -421.43% | 75.00% | 188.89% | -50.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 167.06% | -256.04% | 75.92% | 11.11% | -553.64% |